Johan Rojas, an outfielder for the Philadelphia Phillies, has been handed an 80-game suspension without pay by Major League Baseball (MLB) after testing positive for a prohibited performance-enhancing substance. The league confirmed the suspension following Rojas’ unsuccessful appeal regarding the finding.
### Positive Test Results Lead to Suspension
The suspension stems from a positive test for Boldenone, an anabolic steroid. The announcement arrived shortly after reports surfaced concerning Rojas’ failed test earlier this month, marking a significant setback for the 25-year-old player. As a consequence of this ruling, Rojas will also vacate his place on the Dominican Republic’s roster for the World Baseball Classic (WBC), where the team recently lost to Team USA in the semifinals.
Rojas’ absence will have implications not only for the World Baseball Classic but also for his MLB career. His suspension will carry over into the second half of the season, and should the Phillies qualify for the playoffs, he will not be eligible to participate.
### Impact on Rojas and the Phillies
Rojas, who made his Major League debut in 2023, experienced a turbulent start to the 2025 season. During that year, he posted a batting line of .224/.280/.289 over 71 games, hitting only one home run and accumulating 18 RBIs across 172 plate appearances. His performance led to a demotion earlier this season, but he still managed to appear in 120 games for the Phillies last year.
Before the suspension announcement, Rojas had struggled during spring training, batting just .167 over 24 at-bats. His suspension places him in a challenging position as he now faces a protracted absence from the game during a critical time in the season.
The repercussions of Rojas’ suspension extend beyond his personal setback. With this being the second notable suspension linked to performance-enhancing drugs in recent weeks, it raises questions regarding the ongoing challenges within the league to maintain integrity and fair play. Atlanta Braves outfielder Jurickson Profar was recently handed a 162-game suspension for a second offense related to performance-enhancing drugs, amplifying concerns about the issue.
The MLB continues to emphasize its commitment to combating the use of banned substances among players, and Rojas’ case reinforces the league’s stringent policies.
Source reference: Full report
About The Author
